InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Kruger Kurt H, Director. Insider active across 1 company, notably Qualigen Therapeutics, Inc.. Cumulatively, 1 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €4k. History available since 19 August 2021. The latest transaction was disclosed on 19 August 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Kurt H. Kruger is a Director at Qualigen Therapeutics, Inc. As a board member, he participates in the governance and strategic direction of the company, which focuses on developing innovative treatments in biotechnology.